1718 related articles for article (PubMed ID: 16797371)
1. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
2. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
3. Role of thymus in operational tolerance induction in limb allograft transplant model.
Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
[TBL] [Abstract][Full Text] [Related]
4. Applications of bilateral vascularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier: part II.
Klimczak A; Agaoglu G; Carnevale KA; Siemionow M
Ann Plast Surg; 2006 Oct; 57(4):422-30. PubMed ID: 16998336
[TBL] [Abstract][Full Text] [Related]
5. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier.
Siemionow MZ; Klimczak A; Unal S
Transplant Proc; 2005; 37(1):62-4. PubMed ID: 15808547
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival of composite hemiface/mandible/tongue allografts correlates with multilineage chimerism development in the lymphoid and myeloid compartments of recipients.
Kulahci Y; Klimczak A; Madajka M; Altuntas S; Siemionow M
Transplantation; 2010 Oct; 90(8):843-52. PubMed ID: 20697324
[TBL] [Abstract][Full Text] [Related]
7. Strategies to develop chimerism in vascularized skin allografts across MHC barrier.
Demir Y; Ozmen S; Klimczak A; Mukherjee AL; Siemionow MZ
Microsurgery; 2005; 25(5):415-22. PubMed ID: 16025439
[TBL] [Abstract][Full Text] [Related]
8. New composite tissue allograft model of vascularized bone marrow transplant: the iliac osteomyocutaneous flap.
Nasir S; Klimczak A; Sonmez E; Bozkurt M; Gibson S; Siemionow M
Transpl Int; 2010 Jan; 23(1):90-100. PubMed ID: 19686290
[TBL] [Abstract][Full Text] [Related]
9. A new method of bone marrow transplantation leads to extension of skin allograft survival.
Siemionow M; Ozer K; Izycki D; Unsal M; Klimczak A
Transplant Proc; 2005 Jun; 37(5):2309-14. PubMed ID: 15964406
[TBL] [Abstract][Full Text] [Related]
10. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Siemionow M
Ann Plast Surg; 2006 Mar; 56(3):295-300. PubMed ID: 16508361
[TBL] [Abstract][Full Text] [Related]
11. Intraosseus transplantation of donor-derived hematopoietic stem and progenitor cells induces donor-specific chimerism and extends composite tissue allograft survival.
Siemionow M; Zielinski M; Ozmen S; Izycki D
Transplant Proc; 2005 Jun; 37(5):2303-8. PubMed ID: 15964405
[TBL] [Abstract][Full Text] [Related]
12. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol.
Siemionow M; Oke R; Ozer K; Izycki D; Prajapati R
J Hand Surg Am; 2002 Nov; 27(6):1095-103. PubMed ID: 12457363
[TBL] [Abstract][Full Text] [Related]
13. Composite vascularized skin/bone graft model: a viable source for vascularized bone marrow transplantation.
Siemionow M; Ulusal BG; Ozmen S; Ulusal AE; Ozer K
Microsurgery; 2004; 24(3):200-6. PubMed ID: 15160378
[TBL] [Abstract][Full Text] [Related]
14. Allograft mass as a possible contributing factor to the skin transplant outcome.
Ulusal BG; Ulusal AE; Wei FC; Lin CY
J Surg Res; 2010 Jun; 161(2):321-7. PubMed ID: 20478759
[TBL] [Abstract][Full Text] [Related]
15. Skin allograft survival following intrathymic injection of donor bone marrow.
Cober SR; Randolph MA; Lee WP
J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
[TBL] [Abstract][Full Text] [Related]
16. The effect of A2A adenosine receptor agonist on composite tissue allotransplant survival: an in vivo preliminary study.
Ulusal BG; Ulusal AE; Hung LM; Wei FC
J Surg Res; 2006 Apr; 131(2):261-6. PubMed ID: 16457843
[TBL] [Abstract][Full Text] [Related]
17. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
18. Development of donor-specific chimerism and tolerance in composite tissue allografts under alphabeta-T-cell receptor monoclonal antibody and cyclosporine a treatment protocols.
Ozer K; Izycki D; Zielinski M; Siemionow M
Microsurgery; 2004; 24(3):248-54. PubMed ID: 15160385
[TBL] [Abstract][Full Text] [Related]
19. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate.
Tran HS; Malli D; Chrzanowski FA; Puc MM; Matthews MS; Hewitt CW
J Surg Res; 1999 May; 83(2):136-40. PubMed ID: 10329107
[TBL] [Abstract][Full Text] [Related]
20. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
